Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.

MLA

Couette, Nina, et al. “Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.” Frontiers in Oncology, vol. 12, June 2022, pp. 1–10. EBSCOhost, https://doi.org/10.3389/fonc.2022.854499.

APA

Couette, N., Jarjour, W., Brammer, J. E., & Simon Meara, A. (2022). Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease. Frontiers in Oncology, 12, 1–10. https://doi.org/10.3389/fonc.2022.854499

Chicago

Couette, Nina, Wael Jarjour, Jonathan E. Brammer, and Alexa Simon Meara. 2022. “Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.” Frontiers in Oncology 12 (June): 1–10. doi:10.3389/fonc.2022.854499.